Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
Sort by
Sort ascending
Study title
Condition
Phase
Location
NCT ID
Study title
Condition
Phase
Location
NCT ID
Modifying PEST for Psoriatic Arthritis Screening
Plaque Psoriasis, Psoriatic Arthritis
Na
Canada
NCT06382051
LATAM LOWERS LDL-C
Hypercholesterolaemia
Phase4
Argentina Brazil
NCT06501443
Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase3
Argentina Austria BelgiumCanada Colombia Czechia France Germany Greece Hungary Malaysia Poland Puerto Rico Romania Spain Turkey (Türkiye) United Kingdom United States
View all
NCT06840392
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase3
Australia Belgium CanadaChina France India Japan Poland Romania South Korea Spain Taiwan United States
View all
NCT06744920
Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
Chronic Myeloid Leukemia (CML)
Phase2
France
NCT06514534
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia - Homozygous
Phase3
Austria China GermanyGreece Malaysia Netherlands South Africa Taiwan Turkey (Türkiye) United Kingdom United States
View all
NCT06597006
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Breast Neoplasms
Austria Germany
NCT06830720
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
Dengue
Phase2
Brazil Colombia IndiaMalaysia Singapore Vietnam
View all
NCT06006559
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Prostate Cancer
Phase2, Phase3
Australia Brazil ChinaIsrael Japan Singapore South Korea Taiwan United States
View all
NCT06780670
Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
Progressive Multiple Sclerosis
Phase1, Phase2
Australia Canada FranceGermany Italy Spain Switzerland
View all
NCT06675864
No matching countries found
Search